コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 y for the diagnosis of PTB, in comparison to culture test.
2 e sol-gel TiO2 devices through in-vitro cell culture tests.
3 sensitivity remains suboptimum compared with culture tests.
5 show data that indicate that, while PCR and culture testing agree in the majority of cases, there ar
7 certainty analysis showed that, using annual culture test and culling of only high shedders or cullin
8 ion, empirical therapy for UTI without urine culture testing and overdiagnosis of UTI were common and
9 n the same sputum specimen was compared with culture tests and drug susceptibility testing as referen
10 98 significantly reduced Sox9 transcripts in cultured testes and increased Sox9 levels in ovaries.
11 perfect test performance, incomplete PCR and culture testing, and time-varying changes in cholera inc
12 ology and transmission of tinea imbricata by culturing, testing antifungal sensitivities, and sequenc
13 he Gen-Probe AccuProbe Group B Streptococcus Culture Test (APGB) and the BD GeneOhm StrepB assay (GOS
15 on of the rapid Verigene Gram-negative blood culture test (BC-GN), a microarray that detects 9 genus/
16 ificity) of the Verigene Gram-Positive Blood Culture Test (BC-GP) test to identify 12 Gram-positive b
17 inistic cell cycle IBM model fails the batch culture test, because it has an abrupt drop in cell quot
18 chastic IBM model fails the steady chemostat culture test, because it produces excessive numerical ra
19 tumor cell cultures, and normal ectocervical cultures tested, but no IGF-1 transcripts were detected.
20 istome test and VERIGENE gram-negative blood culture test) could identify susceptibility to 2 newer b
21 ta revealed that the KeyPath MRSA/MSSA blood culture test delivered results a median of 30 h sooner t
22 tandard methods, the KeyPath MRSA/MSSA blood culture test demonstrated a sensitivity, specificity, po
24 ithout PD, as well as in interference tissue culture tests followed by multiple in-house and web-avai
25 xamine the incidence of urinalysis and urine culture testing for select diagnoses and patient factors
26 ual microwell AMPLICOR (Roche) (MWA), and by culture; testing for N. gonorrhoeae was done by CA and c
30 andard for diagnosis of typhoid fever, where culture testing is available, but novel diagnostic modal
32 entation of the Verigene Gram-positive blood culture test led to reductions in time to acceptable ant
33 ed active case-finding with sputum smear and culture testing monthly for 6 months and then once every
35 site and five rural sites, we combined blood-culture testing of hospitalized patients who had a fever
40 l admission consistently predicted increased culture testing, regardless of principal diagnosis or ag
46 1 to 2 days, and based on results from cell culture tests, the probe correctly detected the presence
48 ce of the MicroPhage KeyPath MRSA/MSSA blood culture test was compared to conventional identification
49 s with a sample; on the other hand, when its culture test was negative it was 66.66-100% efficient fo
55 omes of patients with GNB BSIs who had blood culture testing with standard-of-care (SOC) culture and